Resveratrol may be beneficial in treatment of diabetic foot syndrome
Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach...
Gespeichert in:
Veröffentlicht in: | Medical hypotheses 2011-09, Vol.77 (3), p.364-367 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 367 |
---|---|
container_issue | 3 |
container_start_page | 364 |
container_title | Medical hypotheses |
container_volume | 77 |
creator | Bashmakov, Yuriy K Assaad-Khalil, Samir Petyaev, Ivan M |
description | Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS. |
doi_str_mv | 10.1016/j.mehy.2011.05.016 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_885559089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0306987711002271</els_id><sourcerecordid>885559089</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVoabZJv0AOwbee7M5Y1kqCUCj50xYChSQ9C1keU21tK5G0AX_72mzSQw-FgYHhvQfze4ydIVQIuP20q0b6NVc1IFYgquV0xDYoeF3WUso3bAMctqVWUh6z9yntAEA3XL1jxzVulVYaN-zqjtIzRZtjGIrRzkVLy0zUe-ftUPipyJFsHmnKReiLztuWsndFH0Iu0jx1MYx0yt72dkj04WWfsJ831w-X38rbH1-_X365LV2DkEveOSTSqus0J2EVNY2SvQZthdRCowVlFVjijXStaK3e9kKrRjac99AS8hP28ZD7GMPTnlI2o0-OhsFOFPbJKCWE0KD0oqwPShdDSpF68xj9aONsEMwKz-zMCs-s8AwIs5wW0_lL_L4dqftreaW1CC4OAlqefPYUTXKeJkedj-Sy6YL_f_7nf-xu8JN3dvhNM6Vd2MdpwWfQpNqAuV_rW9tDBKhrifwPrCmU9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885559089</pqid></control><display><type>article</type><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</creator><creatorcontrib>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</creatorcontrib><description>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</description><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2011.05.016</identifier><identifier>PMID: 21689891</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Diabetic Foot - drug therapy ; Diabetic Foot - pathology ; Dietary Supplements ; Humans ; Insulin Resistance - physiology ; Internal Medicine ; Signal Transduction - drug effects ; Sirtuin 1 - metabolism ; Sirtuins - metabolism ; Stilbenes - pharmacology ; Stilbenes - therapeutic use ; Wound Healing - drug effects</subject><ispartof>Medical hypotheses, 2011-09, Vol.77 (3), p.364-367</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</citedby><cites>FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0306987711002271$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21689891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bashmakov, Yuriy K</creatorcontrib><creatorcontrib>Assaad-Khalil, Samir</creatorcontrib><creatorcontrib>Petyaev, Ivan M</creatorcontrib><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><description>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</description><subject>Diabetic Foot - drug therapy</subject><subject>Diabetic Foot - pathology</subject><subject>Dietary Supplements</subject><subject>Humans</subject><subject>Insulin Resistance - physiology</subject><subject>Internal Medicine</subject><subject>Signal Transduction - drug effects</subject><subject>Sirtuin 1 - metabolism</subject><subject>Sirtuins - metabolism</subject><subject>Stilbenes - pharmacology</subject><subject>Stilbenes - therapeutic use</subject><subject>Wound Healing - drug effects</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVoabZJv0AOwbee7M5Y1kqCUCj50xYChSQ9C1keU21tK5G0AX_72mzSQw-FgYHhvQfze4ydIVQIuP20q0b6NVc1IFYgquV0xDYoeF3WUso3bAMctqVWUh6z9yntAEA3XL1jxzVulVYaN-zqjtIzRZtjGIrRzkVLy0zUe-ftUPipyJFsHmnKReiLztuWsndFH0Iu0jx1MYx0yt72dkj04WWfsJ831w-X38rbH1-_X365LV2DkEveOSTSqus0J2EVNY2SvQZthdRCowVlFVjijXStaK3e9kKrRjac99AS8hP28ZD7GMPTnlI2o0-OhsFOFPbJKCWE0KD0oqwPShdDSpF68xj9aONsEMwKz-zMCs-s8AwIs5wW0_lL_L4dqftreaW1CC4OAlqefPYUTXKeJkedj-Sy6YL_f_7nf-xu8JN3dvhNM6Vd2MdpwWfQpNqAuV_rW9tDBKhrifwPrCmU9g</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Bashmakov, Yuriy K</creator><creator>Assaad-Khalil, Samir</creator><creator>Petyaev, Ivan M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Resveratrol may be beneficial in treatment of diabetic foot syndrome</title><author>Bashmakov, Yuriy K ; Assaad-Khalil, Samir ; Petyaev, Ivan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-3dc1ee98dd93e5a8e4487f909a579591a08a80ae347cb5ba96f59847433f0be13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Diabetic Foot - drug therapy</topic><topic>Diabetic Foot - pathology</topic><topic>Dietary Supplements</topic><topic>Humans</topic><topic>Insulin Resistance - physiology</topic><topic>Internal Medicine</topic><topic>Signal Transduction - drug effects</topic><topic>Sirtuin 1 - metabolism</topic><topic>Sirtuins - metabolism</topic><topic>Stilbenes - pharmacology</topic><topic>Stilbenes - therapeutic use</topic><topic>Wound Healing - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bashmakov, Yuriy K</creatorcontrib><creatorcontrib>Assaad-Khalil, Samir</creatorcontrib><creatorcontrib>Petyaev, Ivan M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bashmakov, Yuriy K</au><au>Assaad-Khalil, Samir</au><au>Petyaev, Ivan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resveratrol may be beneficial in treatment of diabetic foot syndrome</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>77</volume><issue>3</issue><spage>364</spage><epage>367</epage><pages>364-367</pages><issn>0306-9877</issn><eissn>1532-2777</eissn><abstract>Abstract Diabetic foot syndrome (DFS) is a late-stage complication of type 2 diabetes which originates from interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation all on the background of insulin resistance. Despite astonishing mortality rate pharmacological approach in management of diabetic ulceration is almost non-existent. Foot pressure relief, wound debridement and infection control remain widely accepted options in the treatment of DFS. We hypothesize that resveratrol treatment and subsequent activation of SIRT1 pathway might be highly beneficial for patients with DFS. This prediction is based on multiple lines of evidence implicating resveratrol and sirtuins in restoration of insulin sensitivity, microcirculation, tissue regeneration, function of peripheral nerves and production of cytokines. Stabilized “nutraceutical” formulations of resveratrol with high absorption rate are essential to examine its potential medical benefits since dietary polyphenols are known to be rapidly metabolized by gut microflora and oxidized during absorption. Clinical trials with nutraceutical formulations and placebo are required to understand if resveratrol indeed holds the promise for treatment of DFS.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>21689891</pmid><doi>10.1016/j.mehy.2011.05.016</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-9877 |
ispartof | Medical hypotheses, 2011-09, Vol.77 (3), p.364-367 |
issn | 0306-9877 1532-2777 |
language | eng |
recordid | cdi_proquest_miscellaneous_885559089 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Diabetic Foot - drug therapy Diabetic Foot - pathology Dietary Supplements Humans Insulin Resistance - physiology Internal Medicine Signal Transduction - drug effects Sirtuin 1 - metabolism Sirtuins - metabolism Stilbenes - pharmacology Stilbenes - therapeutic use Wound Healing - drug effects |
title | Resveratrol may be beneficial in treatment of diabetic foot syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T21%3A53%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resveratrol%20may%20be%20beneficial%20in%20treatment%20of%20diabetic%20foot%20syndrome&rft.jtitle=Medical%20hypotheses&rft.au=Bashmakov,%20Yuriy%20K&rft.date=2011-09-01&rft.volume=77&rft.issue=3&rft.spage=364&rft.epage=367&rft.pages=364-367&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2011.05.016&rft_dat=%3Cproquest_cross%3E885559089%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885559089&rft_id=info:pmid/21689891&rft_els_id=1_s2_0_S0306987711002271&rfr_iscdi=true |